Digital Reuters Pharma USA 2024 – Nick Altebrando and Shireen Saxena When it comes to patient-facing AI in healthcare, ChatGPT, with its tendency toward hallucination, is not going to cut it.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.